The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Leptin revisited: its mechanism of action and potential for treating diabetes
Open accessAbstract
Since the discovery of leptin in 1994, we now have a better understanding of the cellular and molecular mechanisms underlying its biological effects. In addition to its established anti-obesity effects, leptin exerts antidiabetic actions that are independent of its regulation of body weight and food intake. In particular, leptin can correct diabetes in animal models of type 1 and type 2 diabetes. In addition, long-term leptin replacement therapy improves glycaemic control, insulin sensitivity and plasma triglycerides in patients with severe insulin resistance due to lipodystrophy. These results have spurred enthusiasm for the use of leptin therapy to treat diabetes. Here, we review the current understanding of the glucoregulatory functions of leptin, emphasizing its central mechanisms of action and lessons learned from clinical studies, and discuss possible therapeutic applications of leptin in the treatment of type 1 and type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–223 of 223
BiaCore analysis of leptin–leptin receptor interaction: evidence for 1:1 stoichiometry
Mistrík, P., Moreau, F., & Allen, J. M. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.01.022 · Cited by 50
Levi, J., Gray, S. L., Speck, M., Huynh, F. K., Babich, S. L., Gibson, W. T., & Kieffer, T. J. (2011) · Endocrinology · doi:10.1210/en.2011-0185 · Cited by 48
Kojima, S., Asakawa, A., Amitani, H., Sakoguchi, T., Ueno, N., Inui, A., & Kalra, S. P. (2009) · Peptides · doi:10.1016/j.peptides.2009.01.007 · Cited by 47
Cross-regulation of JAK and Src kinases
Ingley, E., & Klinken, S. P. (2006) · Growth Factors · doi:10.1080/08977190500368031 · Cited by 47
da Silva, A. A., do Carmo, J. M., Freeman, J. N., Tallam, L. S., & Hall, J. E. (2009) · Diabetes · doi:10.2337/db08-1221 · Cited by 47
Heijboer, A. C., van den Hoek, A. M., Pijl, H., Voshol, P. J., Havekes, L. M., Romijn, J. A., & Corssmit, E. P. M. (2005) · Diabetologia · doi:10.1007/s00125-005-1838-8 · Cited by 43
Metabolic Disease Drug Discovery— “Hitting the Target” Is Easier Said Than Done
Moller, D. E. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.012 · Cited by 43
Metformin Beyond Diabetes: New Life for an Old Drug
Rotella, C. M., Monami, M., & Mannucci, E. (2006) · Current Diabetes Reviews · doi:10.2174/157339906777950651 · Cited by 41
Li, M., Li, Z., Morris, D. L., & Rui, L. (2007) · Endocrinology · doi:10.1210/en.2006-1010 · Cited by 39
Hitting the Target: New Treatments for Cystic Fibrosis
Davis, S. D., & Ferkol, T. W. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201008-1311ed · Cited by 37
Flier, J. S., & Maratos–Flier, E. (2010) · Cell · doi:10.1016/j.cell.2010.09.021 · Cited by 35
Leptin Deficiency Per Se Dictates Body Composition and Insulin Action in ob/ob Mice
Van Den Hoek, A. M., Teusink, B., Voshol, P. J., Havekes, L. M., Romijn, J. A., & Pijl, H. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01626.x · Cited by 34
Cao, Y., Nakata, M., Okamoto, S., Takano, E., Yada, T., Minokoshi, Y., Hirata, Y., Nakajima, K., Iskandar, K., Hayashi, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018324 · Cited by 33
Robertson, S., Ishida-Takahashi, R., Tawara, I., Hu, J., Patterson, C. M., Jones, J. C., Kulkarni, R. N., & Myers, M. G. (2010) · Diabetes · doi:10.2337/db09-1556 · Cited by 30
Sekhar, R. V., Jahoor, F., Iyer, D., Guthikonda, A., Paranilam, J., Elhaj, F., Coraza, I., & Balasubramanyam, A. (2012) · Metabolism · doi:10.1016/j.metabol.2012.03.013 · Cited by 29
Banno, R., Arima, H., Hayashi, M., Goto, M., Watanabe, M., Sato, I., Ozaki, N., Nagasaki, H., Ozaki, N., & Oiso, Y. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.019 · Cited by 28
Combined amylin–leptin treatment lowers blood pressure and adiposity in lean and obese rats
Seth, R., Knight, W. D., & Overton, J. M. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.262 · Cited by 28
Benomar, Y., Berthou, F., Vacher, C., Bailleux, V., Gertler, A., Djiane, J., & Taouis, M. (2008) · Endocrinology · doi:10.1210/en.2008-1097 · Cited by 28
Role of proopiomelanocortin neurons and peptides in the regulation of energy homeostasis.
Low, M. J. (2004) · PubMed · Cited by 21
Glucagon Responses of Isolated a Cells to Glucose, Insulin, Somatostatin, and Leptin
Chen, L., Philippé, J., & Unger, R. H. (2011) · Endocrine Practice · doi:10.4158/ep11101.or · Cited by 17
The effect of the PPARγ ligand rosiglitazone on energy balance regulation
Joosen, A. M. C. P., Bakker, A. H. F., Gering, M. J. A., & Westerterp, K. R. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.592 · Cited by 17
“AMPing up” our understanding of the hypothalamic control of energy balance
Williams, K. W., Coppari, R., & Elmquist, J. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32975 · Cited by 9
Self-citationLeckström, A., Lew, P. S., Poritsanos, N. J., & Mizuno, T. M. (2011) · Neuropeptides · doi:10.1016/j.npep.2010.12.005 · Cited by 4
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Li, H., Yang, Y., Hong, W., Huang, M., Wu, M., & Zhao, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0089-y · Cited by 1,715
Adipocytokines in Obesity and Metabolic Disease
Cao, H. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0339 · Cited by 705
Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism
Park, H.-K., & Ahima, R. S. (2015) · Metabolism · doi:10.1016/j.metabol.2014.08.004 · Cited by 669
Structure, production and signaling of leptin
Münzberg, H., & Morrison, C. D. (2015) · Metabolism · doi:10.1016/j.metabol.2014.09.010 · Cited by 452
Metadata
- Authors
- Coppari, R., & Bjørbæk, C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-08-31
- Volume
- 11
- Issue
- 9
- Pages
- 692-708
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2008768221
- Cited by
- 293
- References
- 223
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.